The structure of the catalytic portion of human HMG-CoA reductase

This publication has 28 references indexed in Scilit:

• Sterols and Isoprenoids: Signaling Molecules Derived from the Cholesterol Biosynthetic Pathway
  Annual Review of Biochemistry, 1999
• Sequence Comparisons Reveal Two Classes of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase
  Molecular Genetics and Metabolism, 1999
• Inhibition of the 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Pathway Induces p53-independent Transcriptional Regulation of p21 in Human Prostate Carcinoma Cells
  Published by Elsevier ,1998
• Cholesterol Lowering in the Management of Coronary Artery Disease: The Clinical Implications of Recent Trials
  The American Journal of Medicine, 1998
• Results of Recent Large Cholesterol-Lowering Trials and Implications for Clinical Management
  The American Journal of Cardiology, 1997
• Molecular Dissection of the Role of the Membrane Domain in the Regulated Degradation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase
  Published by Elsevier ,1995
• Modulation of Syrian hamster 3-hydroxy-3-methylglutaryl-CoA reductase activity by phosphorylation. Role of serine 871.
  Published by Elsevier ,1994
• Importance of mevalonate‐derived products in the control of HMG‐CoA reductase activity and growth of human lung adenocarcinoma cell line a549
  International Journal of Cancer, 1993
• Regulation of the mevalonate pathway
  Nature, 1990
• Membrane-bound domain of HMG CoA reductase is required for sterol-enhanced degradation of the enzyme
  Cell, 1985